Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-21

Clinical Trial Update: Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of busulfan in adult acute leukemia patients undergoing allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUSULFAN (Busulfan)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acute Leukemia | Phase 2 | Status: UNKNOWN